|
|
Volumn 371, Issue 8, 2014, Pages 783-784
|
|
Treatments for idiopathic pulmonary fibrosis: Dr. King and colleagues reply
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PIRFENIDONE;
PLACEBO;
ANTIFIBRINOLYTIC AGENT;
ENZYME INHIBITOR;
PYRIDONE DERIVATIVE;
ALL CAUSE MORTALITY;
CAUSE OF DEATH;
CLINICAL TRIAL (TOPIC);
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
FIBROSING ALVEOLITIS;
FORCED VITAL CAPACITY;
HAZARD RATIO;
HUMAN;
INCIDENCE;
LETTER;
LUNG TRANSPLANTATION;
MORTALITY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SENSITIVITY ANALYSIS;
SURGICAL RISK;
TREATMENT OUTCOME;
FEMALE;
MALE;
NOTE;
ANTIFIBRINOLYTIC AGENTS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
IDIOPATHIC PULMONARY FIBROSIS;
MALE;
PYRIDONES;
|
|
EID: 84906911106
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1407776 Document Type: Letter |
|
Times cited : (13)
|
|
References (3)
|
